世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
マラリア診断薬市場。世界の産業動向、シェア、サイズ、成長、機会、そして2021-2026年の予測Malaria Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026 The global malaria diagnostics market exhibited moderate growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of 5.2% during 2021-2026. Keeping in mind the unc... もっと見る
サマリーThe global malaria diagnostics market exhibited moderate growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of 5.2% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.Malaria diagnostics refers to the clinical tests conducted to detect the presence of the infection in individuals. Malaria is caused by the bite of an infected female Anopheles mosquito, which leads to the transfer of Plasmodium parasites into the body. Some common symptoms include fever, fatigue, nausea and headaches. The infection is diagnosed through various rapid diagnostics, microscopy and molecular diagnostic tests. These tests use antigen detection and serology techniques using indirect immunofluorescence (IFA) or enzyme-linked immunosorbent assay (ELISA). They are widely used in hospitals, laboratories, clinics, research institutes and diagnostic centers. Malaria Diagnostics Market Trends: The increasing prevalence of malaria across the globe is one of the key factors creating a positive outlook for the market. Malaria is a life-threatening infection that has caused a significant loss of human lives, especially in developing nations. However, rising awareness among the masses regarding the available diagnostic and treatment alternatives for malaria is providing a thrust to the market growth. Healthcare centers and diagnostic laboratories are widely adopting microscopic diagnostics to identify the parasite at different stages and design suitable treatment plans. Additionally, various technological advancements, such as the development of the Quantitative Buffy Coat (QBC) method and peripheral blood smear technique for diagnosing malaria, are acting as other growth-inducing factors. In line with this, the availability of Point-of-Care (POC) diagnostic devices for enhanced accuracy is also contributing to the growth of the market. Other factors, including rising healthcare expenditure capacities of the masses, along with the implementation of favorable government policies promoting public health, are anticipated to drive the market toward growth. Key Market Segmentation: IMARC Group provides an analysis of the key trends in each sub-segment of the global malaria diagnostics market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on region, technology and end use. Breakup by Technology: Microscopy Rapid Diagnostic Tests (RDTs) Molecular Diagnostic Tests Conventional PCR Real-Time PCR (qPCR) Breakup by End Use: Hospital Clinics Diagnostic Centers Breakup by Region: North America United States Canada Asia-Pacific China Japan India South Korea Australia Indonesia Others Europe Germany France United Kingdom Italy Spain Russia Others Latin America Brazil Mexico Others Middle East and Africa Competitive Landscape: The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Access Bio, Beckman Coulter Inc. (Danaher Corporation), bioMérieux SA (Compagnie Merieux Alliance), Bio-Rad Laboratories Inc., Nikon Corporation, Novartis AG, Olympus Corporation, Premier Medical Corporation Pvt. Ltd., Siemens Healthcare GmbH (Siemens AG), Sysmex Corporation and Thermo Fisher Scientific Inc. Key Questions Answered in This Report: How has the global malaria diagnostics market performed so far and how will it perform in the coming years? What has been the impact of COVID-19 on the global malaria diagnostics market? What are the key regional markets? What is the breakup of the market based on the technology? What is the breakup of the market based on the end use? What are the various stages in the value chain of the industry? What are the key driving factors and challenges in the industry? What is the structure of the global malaria diagnostics market and who are the key players? What is the degree of competition in the industry? 目次1 Preface2 Scope and Methodology 2.1 Objectives of the Study 2.2 Stakeholders 2.3 Data Sources 2.3.1 Primary Sources 2.3.2 Secondary Sources 2.4 Market Estimation 2.4.1 Bottom-Up Approach 2.4.2 Top-Down Approach 2.5 Forecasting Methodology 3 Executive Summary 4 Introduction 4.1 Overview 4.2 Key Industry Trends 5 Global Malaria Diagnostics Market 5.1 Market Overview 5.2 Market Performance 5.3 Impact of COVID-19 5.4 Market Forecast 6 Market Breakup by Technology 6.1 Microscopy 6.1.1 Market Trends 6.1.2 Market Forecast 6.2 Rapid Diagnostic Tests (RDTs) 6.2.1 Market Trends 6.2.2 Market Forecast 6.3 Molecular Diagnostic Tests 6.3.1 Market Trends 6.3.2 Key Segments 6.3.2.1 Conventional PCR 6.3.2.2 Real-Time PCR (qPCR) 6.3.3 Market Forecast 7 Market Breakup by End Use 7.1 Hospital 7.1.1 Market Trends 7.1.2 Market Forecast 7.2 Clinics 7.2.1 Market Trends 7.2.2 Market Forecast 7.3 Diagnostic Centers 7.3.1 Market Trends 7.3.2 Market Forecast 8 Market Breakup by Region 8.1 North America 8.1.1 United States 8.1.1.1 Market Trends 8.1.1.2 Market Forecast 8.1.2 Canada 8.1.2.1 Market Trends 8.1.2.2 Market Forecast 8.2 Asia-Pacific 8.2.1 China 8.2.1.1 Market Trends 8.2.1.2 Market Forecast 8.2.2 Japan 8.2.2.1 Market Trends 8.2.2.2 Market Forecast 8.2.3 India 8.2.3.1 Market Trends 8.2.3.2 Market Forecast 8.2.4 South Korea 8.2.4.1 Market Trends 8.2.4.2 Market Forecast 8.2.5 Australia 8.2.5.1 Market Trends 8.2.5.2 Market Forecast 8.2.6 Indonesia 8.2.6.1 Market Trends 8.2.6.2 Market Forecast 8.2.7 Others 8.2.7.1 Market Trends 8.2.7.2 Market Forecast 8.3 Europe 8.3.1 Germany 8.3.1.1 Market Trends 8.3.1.2 Market Forecast 8.3.2 France 8.3.2.1 Market Trends 8.3.2.2 Market Forecast 8.3.3 United Kingdom 8.3.3.1 Market Trends 8.3.3.2 Market Forecast 8.3.4 Italy 8.3.4.1 Market Trends 8.3.4.2 Market Forecast 8.3.5 Spain 8.3.5.1 Market Trends 8.3.5.2 Market Forecast 8.3.6 Russia 8.3.6.1 Market Trends 8.3.6.2 Market Forecast 8.3.7 Others 8.3.7.1 Market Trends 8.3.7.2 Market Forecast 8.4 Latin America 8.4.1 Brazil 8.4.1.1 Market Trends 8.4.1.2 Market Forecast 8.4.2 Mexico 8.4.2.1 Market Trends 8.4.2.2 Market Forecast 8.4.3 Others 8.4.3.1 Market Trends 8.4.3.2 Market Forecast 8.5 Middle East and Africa 8.5.1 Market Trends 8.5.2 Market Breakup by Country 8.5.3 Market Forecast 9 SWOT Analysis 9.1 Overview 9.2 Strengths 9.3 Weaknesses 9.4 Opportunities 9.5 Threats 10 Value Chain Analysis 11 Porters Five Forces Analysis 11.1 Overview 11.2 Bargaining Power of Buyers 11.3 Bargaining Power of Suppliers 11.4 Degree of Competition 11.5 Threat of New Entrants 11.6 Threat of Substitutes 12 Price Analysis 13 Competitive Landscape 13.1 Market Structure 13.2 Key Players 13.3 Profiles of Key Players 13.3.1 Abbott Laboratories 13.3.1.1 Company Overview 13.3.1.2 Product Portfolio 13.3.1.3 Financials 13.3.1.4 SWOT Analysis 13.3.2 Access Bio 13.3.2.1 Company Overview 13.3.2.2 Product Portfolio 13.3.2.3 Financials 13.3.3 Beckman Coulter Inc. (Danaher Corporation) 13.3.3.1 Company Overview 13.3.3.2 Product Portfolio 13.3.3.3 SWOT Analysis 13.3.4 bioMérieux SA (Compagnie Merieux Alliance) 13.3.4.1 Company Overview 13.3.4.2 Product Portfolio 13.3.4.3 Financials 13.3.4.4 SWOT Analysis 13.3.5 Bio-Rad Laboratories Inc. 13.3.5.1 Company Overview 13.3.5.2 Product Portfolio 13.3.5.3 Financials 13.3.5.4 SWOT Analysis 13.3.6 Nikon Corporation 13.3.6.1 Company Overview 13.3.6.2 Product Portfolio 13.3.6.3 Financials 13.3.6.4 SWOT Analysis 13.3.7 Novartis AG 13.3.7.1 Company Overview 13.3.7.2 Product Portfolio 13.3.7.3 Financials 13.3.7.4 SWOT Analysis 13.3.8 Olympus Corporation 13.3.8.1 Company Overview 13.3.8.2 Product Portfolio 13.3.8.3 Financials 13.3.8.4 SWOT Analysis 13.3.9 Premier Medical Corporation Pvt. Ltd. 13.3.9.1 Company Overview 13.3.9.2 Product Portfolio 13.3.10 Siemens Healthcare GmbH (Siemens AG) 13.3.10.1 Company Overview 13.3.10.2 Product Portfolio 13.3.10.3 Financials 13.3.10.4 SWOT Analysis 13.3.11 Sysmex Corporation 13.3.11.1 Company Overview 13.3.11.2 Product Portfolio 13.3.11.3 Financials 13.3.11.4 SWOT Analysis 13.3.12 Thermo Fisher Scientific Inc 13.3.12.1 Company Overview 13.3.12.2 Product Portfolio 13.3.12.3 Financials 13.3.12.4 SWOT Analysis
SummaryThe global malaria diagnostics market exhibited moderate growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of 5.2% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.Malaria diagnostics refers to the clinical tests conducted to detect the presence of the infection in individuals. Malaria is caused by the bite of an infected female Anopheles mosquito, which leads to the transfer of Plasmodium parasites into the body. Some common symptoms include fever, fatigue, nausea and headaches. The infection is diagnosed through various rapid diagnostics, microscopy and molecular diagnostic tests. These tests use antigen detection and serology techniques using indirect immunofluorescence (IFA) or enzyme-linked immunosorbent assay (ELISA). They are widely used in hospitals, laboratories, clinics, research institutes and diagnostic centers. Malaria Diagnostics Market Trends: The increasing prevalence of malaria across the globe is one of the key factors creating a positive outlook for the market. Malaria is a life-threatening infection that has caused a significant loss of human lives, especially in developing nations. However, rising awareness among the masses regarding the available diagnostic and treatment alternatives for malaria is providing a thrust to the market growth. Healthcare centers and diagnostic laboratories are widely adopting microscopic diagnostics to identify the parasite at different stages and design suitable treatment plans. Additionally, various technological advancements, such as the development of the Quantitative Buffy Coat (QBC) method and peripheral blood smear technique for diagnosing malaria, are acting as other growth-inducing factors. In line with this, the availability of Point-of-Care (POC) diagnostic devices for enhanced accuracy is also contributing to the growth of the market. Other factors, including rising healthcare expenditure capacities of the masses, along with the implementation of favorable government policies promoting public health, are anticipated to drive the market toward growth. Key Market Segmentation: IMARC Group provides an analysis of the key trends in each sub-segment of the global malaria diagnostics market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on region, technology and end use. Breakup by Technology: Microscopy Rapid Diagnostic Tests (RDTs) Molecular Diagnostic Tests Conventional PCR Real-Time PCR (qPCR) Breakup by End Use: Hospital Clinics Diagnostic Centers Breakup by Region: North America United States Canada Asia-Pacific China Japan India South Korea Australia Indonesia Others Europe Germany France United Kingdom Italy Spain Russia Others Latin America Brazil Mexico Others Middle East and Africa Competitive Landscape: The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Access Bio, Beckman Coulter Inc. (Danaher Corporation), bioMérieux SA (Compagnie Merieux Alliance), Bio-Rad Laboratories Inc., Nikon Corporation, Novartis AG, Olympus Corporation, Premier Medical Corporation Pvt. Ltd., Siemens Healthcare GmbH (Siemens AG), Sysmex Corporation and Thermo Fisher Scientific Inc. Key Questions Answered in This Report: How has the global malaria diagnostics market performed so far and how will it perform in the coming years? What has been the impact of COVID-19 on the global malaria diagnostics market? What are the key regional markets? What is the breakup of the market based on the technology? What is the breakup of the market based on the end use? What are the various stages in the value chain of the industry? What are the key driving factors and challenges in the industry? What is the structure of the global malaria diagnostics market and who are the key players? What is the degree of competition in the industry? Table of Contents1 Preface2 Scope and Methodology 2.1 Objectives of the Study 2.2 Stakeholders 2.3 Data Sources 2.3.1 Primary Sources 2.3.2 Secondary Sources 2.4 Market Estimation 2.4.1 Bottom-Up Approach 2.4.2 Top-Down Approach 2.5 Forecasting Methodology 3 Executive Summary 4 Introduction 4.1 Overview 4.2 Key Industry Trends 5 Global Malaria Diagnostics Market 5.1 Market Overview 5.2 Market Performance 5.3 Impact of COVID-19 5.4 Market Forecast 6 Market Breakup by Technology 6.1 Microscopy 6.1.1 Market Trends 6.1.2 Market Forecast 6.2 Rapid Diagnostic Tests (RDTs) 6.2.1 Market Trends 6.2.2 Market Forecast 6.3 Molecular Diagnostic Tests 6.3.1 Market Trends 6.3.2 Key Segments 6.3.2.1 Conventional PCR 6.3.2.2 Real-Time PCR (qPCR) 6.3.3 Market Forecast 7 Market Breakup by End Use 7.1 Hospital 7.1.1 Market Trends 7.1.2 Market Forecast 7.2 Clinics 7.2.1 Market Trends 7.2.2 Market Forecast 7.3 Diagnostic Centers 7.3.1 Market Trends 7.3.2 Market Forecast 8 Market Breakup by Region 8.1 North America 8.1.1 United States 8.1.1.1 Market Trends 8.1.1.2 Market Forecast 8.1.2 Canada 8.1.2.1 Market Trends 8.1.2.2 Market Forecast 8.2 Asia-Pacific 8.2.1 China 8.2.1.1 Market Trends 8.2.1.2 Market Forecast 8.2.2 Japan 8.2.2.1 Market Trends 8.2.2.2 Market Forecast 8.2.3 India 8.2.3.1 Market Trends 8.2.3.2 Market Forecast 8.2.4 South Korea 8.2.4.1 Market Trends 8.2.4.2 Market Forecast 8.2.5 Australia 8.2.5.1 Market Trends 8.2.5.2 Market Forecast 8.2.6 Indonesia 8.2.6.1 Market Trends 8.2.6.2 Market Forecast 8.2.7 Others 8.2.7.1 Market Trends 8.2.7.2 Market Forecast 8.3 Europe 8.3.1 Germany 8.3.1.1 Market Trends 8.3.1.2 Market Forecast 8.3.2 France 8.3.2.1 Market Trends 8.3.2.2 Market Forecast 8.3.3 United Kingdom 8.3.3.1 Market Trends 8.3.3.2 Market Forecast 8.3.4 Italy 8.3.4.1 Market Trends 8.3.4.2 Market Forecast 8.3.5 Spain 8.3.5.1 Market Trends 8.3.5.2 Market Forecast 8.3.6 Russia 8.3.6.1 Market Trends 8.3.6.2 Market Forecast 8.3.7 Others 8.3.7.1 Market Trends 8.3.7.2 Market Forecast 8.4 Latin America 8.4.1 Brazil 8.4.1.1 Market Trends 8.4.1.2 Market Forecast 8.4.2 Mexico 8.4.2.1 Market Trends 8.4.2.2 Market Forecast 8.4.3 Others 8.4.3.1 Market Trends 8.4.3.2 Market Forecast 8.5 Middle East and Africa 8.5.1 Market Trends 8.5.2 Market Breakup by Country 8.5.3 Market Forecast 9 SWOT Analysis 9.1 Overview 9.2 Strengths 9.3 Weaknesses 9.4 Opportunities 9.5 Threats 10 Value Chain Analysis 11 Porters Five Forces Analysis 11.1 Overview 11.2 Bargaining Power of Buyers 11.3 Bargaining Power of Suppliers 11.4 Degree of Competition 11.5 Threat of New Entrants 11.6 Threat of Substitutes 12 Price Analysis 13 Competitive Landscape 13.1 Market Structure 13.2 Key Players 13.3 Profiles of Key Players 13.3.1 Abbott Laboratories 13.3.1.1 Company Overview 13.3.1.2 Product Portfolio 13.3.1.3 Financials 13.3.1.4 SWOT Analysis 13.3.2 Access Bio 13.3.2.1 Company Overview 13.3.2.2 Product Portfolio 13.3.2.3 Financials 13.3.3 Beckman Coulter Inc. (Danaher Corporation) 13.3.3.1 Company Overview 13.3.3.2 Product Portfolio 13.3.3.3 SWOT Analysis 13.3.4 bioMérieux SA (Compagnie Merieux Alliance) 13.3.4.1 Company Overview 13.3.4.2 Product Portfolio 13.3.4.3 Financials 13.3.4.4 SWOT Analysis 13.3.5 Bio-Rad Laboratories Inc. 13.3.5.1 Company Overview 13.3.5.2 Product Portfolio 13.3.5.3 Financials 13.3.5.4 SWOT Analysis 13.3.6 Nikon Corporation 13.3.6.1 Company Overview 13.3.6.2 Product Portfolio 13.3.6.3 Financials 13.3.6.4 SWOT Analysis 13.3.7 Novartis AG 13.3.7.1 Company Overview 13.3.7.2 Product Portfolio 13.3.7.3 Financials 13.3.7.4 SWOT Analysis 13.3.8 Olympus Corporation 13.3.8.1 Company Overview 13.3.8.2 Product Portfolio 13.3.8.3 Financials 13.3.8.4 SWOT Analysis 13.3.9 Premier Medical Corporation Pvt. Ltd. 13.3.9.1 Company Overview 13.3.9.2 Product Portfolio 13.3.10 Siemens Healthcare GmbH (Siemens AG) 13.3.10.1 Company Overview 13.3.10.2 Product Portfolio 13.3.10.3 Financials 13.3.10.4 SWOT Analysis 13.3.11 Sysmex Corporation 13.3.11.1 Company Overview 13.3.11.2 Product Portfolio 13.3.11.3 Financials 13.3.11.4 SWOT Analysis 13.3.12 Thermo Fisher Scientific Inc 13.3.12.1 Company Overview 13.3.12.2 Product Portfolio 13.3.12.3 Financials 13.3.12.4 SWOT Analysis
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（診断薬）の最新刊レポート
IMARC Services Private Limited.社の診断薬分野での最新刊レポート
本レポートと同じKEY WORD（diagnostics）の最新刊レポート
よくあるご質問IMARC Services Private Limited.社はどのような調査会社ですか?インドに調査拠点を持つ調査会社。幅広い分野をカバーしていますがケミカルに特に焦点を当てています。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/13 10:29 155.97 円 166.03 円 201.39 円 |
